Remove Documentation Remove Drug Pricing Remove Vaccines
article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108
article thumbnail

Maximise Profit by Becoming a Drug Tariff Pro

pharmacy mentor

In this article, we will delve into the essential aspects of the Drug Tariff to help you become a Drug Tariff Pro and optimise your pharmacy operations. The Drug Tariff is notoriously difficult to access and search online, making it impractical for quick decision making during the prescription dispensing process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma in Brief’s 2023 Year in Review and Trends for 2024

Pharma in Brief

Expected highlights for 2024 include a final PTA regime, more details on PMPRB drug pricing guidelines and national pharmacare, and fall-out from the US mass drug importation program targeting Canadian medicines. billion over three years to help increase drug access and affordability (see here ).The Rare disease strategy.

article thumbnail

Pricing, Profits and Progress: Pharma’s Post-COVID Priorities

pharmaphorum

The need for firms to make a reasonable profit is paramount in today’s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges. The Big Misconception. Is the Middleman at Fault?

article thumbnail

India is rising from a CDMO perspective when it comes to biologics

Express Pharma

India trends: The power of AI and data analytics is ushering generative AI, along with AI and ML, into the Indian biopharma industry, contributing to areas such as disease understanding and vaccine development. When you’re designing and then beginning to execute a clinical trial, you must author about 90 documents for that trial.